# THROMBIN-JMI (thrombin, topical (bovine)) by Pfizer Laboratories Div Pfizer Inc: new plasma derivative listing

**Launch Signal Score:** 70/100

| Field | Value |
|---|---|
| Product | THROMBIN-JMI |
| Generic name | thrombin, topical (bovine) |
| NDC | 60793-333 |
| Labeler | Pfizer Laboratories Div Pfizer Inc |
| Product type | PLASMA DERIVATIVE |
| Approval pathway | BLA |
| Application number | BLA102865 |
| Dosage form | LIQUID |
| Route | TOPICAL |
| Active ingredients | THROMBIN 5000 [iU]/5mL |
| Marketing start | 2026-08-31 |
| Package configurations | 1 |

## Why this score
- Prescription or biologic product.
- Brand or biologic launch.

Source: U.S. FDA National Drug Code (NDC) Directory via openFDA (https://dailymed.nlm.nih.gov/dailymed/search.cfm?labeltype=all&query=60793-333). Last refreshed: 2026-11-03T18:09:00.764Z.
Listing data comes from the FDA NDC directory via openFDA; a listing is not an FDA approval or endorsement and may be updated or withdrawn. Informational only; not medical advice.